北米の脂肪減少市場 – 業界動向と2033年までの予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Free Sample Report 無料サンプルレポート Inquire Before Buying 事前に問い合わせる Buy Now今すぐ購入

北米の脂肪減少市場 – 業界動向と2033年までの予測

  • Medical Devices
  • Published Report
  • Sep 2023
  • North America
  • 350 ページ
  • テーブル数: 530
  • 図の数: 44

アジャイルなサプライチェーンコンサルティングで関税の課題を回避

サプライチェーンエコシステム分析は、現在DBMRレポートの一部です

北米の脂肪除去市場、タイプ別(外科的脂肪除去、非侵襲的脂肪除去、低侵襲的)、用途別(腹部脂肪、太もも脂肪、臀部脂肪、上腕脂肪、顔面脂肪沈着、膝脂肪)、性別別(女性と男性)、年齢層別(成人、高齢者、小児)、エンドユーザー別(病院、多専門クリニック、皮膚科センター、メディカルスパ、ビューティーセンター、その他)、流通チャネル別(直接入札、小売販売、サードパーティ販売業者、その他)、業界動向および2033年までの予測。

北米の脂肪減少市場

北米の脂肪減少市場の分析と洞察

北米の脂肪除去市場は、低侵襲および非侵襲手術の需要増加と美容機能に関する男女間の格差の縮小により、予測期間中に成長すると予想されています。市場は、美意識と美の基準の高まり、技術の進歩の進展にも影響を受けています。しかし、北米の脂肪除去市場は、手術の高額な費用、手術に伴うリスクの増大、製品リコールにより阻害されると予想されています。

北米の脂肪減少市場北米の脂肪減少市場

カスタマイズされた治療計画、他の美容処置との統合、若年成人の脂肪減少に関する信念と傾向、包括性と多様性への重点、製品ラインの拡大は、市場成長の機会として機能すると予想されます。ただし、処置の有効性と持続性が低く、回復に時間がかかることから、市場成長の課題となることが予想されます。

脂肪減少市場への需要は先進国と発展途上国の両方で増加しており、その理由は脂肪減少製品の有効性と入手しやすさにあります。そのため、多くの市場プレーヤーが革新的な脂肪減少製品を提供しており、北米の脂肪減少市場の成長に道を開いています。

Data Bridge Market Research は、北米の脂肪減少市場は予測期間中に 9.9% の CAGR で成長し、2033 年までに 117 億 7,356 万米ドルの価値に達すると予測しています。

レポートメトリック

詳細

予測期間

2023年から2033年

基準年

2022

歴史的な年

2021 (2015~2020年にカスタマイズ可能)

定量単位

収益(百万米ドル)

対象セグメント

タイプ (外科的脂肪除去、非侵襲的脂肪除去、低侵襲)、用途 (腹部脂肪、太もも脂肪、臀部脂肪、上腕脂肪、顔面脂肪沈着、膝脂肪)、性別 (女性と男性)、年齢層 (成人、高齢者、小児)、エンドユーザー (病院、多科クリニック、皮膚科センター、メディカル スパおよびビューティー センター、その他)、流通チャネル (直接入札、小売販売、サードパーティ ディストリビューター、その他)

対象国

米国、カナダ、メキシコ、コスタリカ、ドミニカ共和国、パナマ、エルサルバドル、グアテマラ、ホンジュラス、ニカラグア

対象となる市場プレーヤー

Hironic Co Ltd、AbbVie Inc.、Cynosure、Alma Lasers、Candela Corporation、Merz Pharma、Solta Medical(Bausch & Lomb Incorporated の子会社)、Cutera、MicroAire Surgical Instruments、LLC.、Mentor Worldwide LLC、Venus Concept、Erchonia Corporation、BTL Group of Companies、Leaderma Inc.、MÖLLER Medical、Fotona、Implantech など。

北米の脂肪減少市場の定義

脂肪減少とは、個人の体内の体脂肪または脂肪組織の量を減らすことです。これには、体重減少を促進し、体脂肪の全体的な割合を減らすことを目的とした戦略と技術が含まれます。体脂肪の減少は、外科的処置と非外科的処置によって行うことができます。レーザー脂肪分解、涙液脂肪分解、脂肪吸引、注射治療など、さまざまな治療法があります。

北米の脂肪減少市場の動向

このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。    

ドライバー

  • 低侵襲および非侵襲手術の需要増加

脂肪減少技術では、レーザーやその他のエネルギーベースの装置を含む従来の方法に比べて、低侵襲および非侵襲の処置の使用が移行しています。外科的または非外科的処置の使用のために、低侵襲処置用に特別に設計された器具が開発されています。

低侵襲手術は、観察スコープと特別装備の手術器具の助けを借りて行われる処置です。低侵襲処置を使用すると、切開がないか、切開が最小限で回復時間が短いため、低侵襲処置の需要と使用が増加します。処置の増加のその他の理由としては、高齢化の増加と、医療要件が最大限である患者に優しい技術を含む医療施設の必要性が挙げられます。これにより、医療施設の負担がさらに軽減されます。

低侵襲/非侵襲手術は患者の快適さに合致しています。副作用はほとんどなく、回復時間も非常に短いです。そのため、人々は美容整形手術を受けることに安心感を覚えます。したがって、低侵襲および非侵襲手術の需要増加が市場の牽引役となることが期待されます。

拘束

  • 手続きにかかる費用が高い

最新技術に基づく脂肪減少装置は、超音波、レーザー補助、または高周波補助の脂肪減少装置などの技術的に高度な手段を使用して脂肪を減らすことにより、さまざまな体の部分の調子を整え、引き締めるのに役立ちます。脂肪減少のコストは、場所や地域によって大きく異なります。脂肪減少のコストを決定する主な要因には、手順のために確定された医療機関またはクリニック、治療領域、影響を受けた領域、患者の入院期間、手術の複雑さなどがあります。手順のコストが高いのは、手術のさまざまなチェックポイントと、そのような手順を実行するためのハイテクな手段の使用によるものです。技術的に高度な脂肪減少装置のコストが高いため、手順のコストも比例して高騰し、手順のコストが高いため、市場の需要が妨げられると予想されます。

北米の脂肪減少市場

機会

  • カスタマイズされた治療計画と他の美容処置との統合

北米の脂肪減少市場の企業は、カスタマイズされた治療計画と、脂肪減少処置を他の美容処置と統合することで、カスタマイズされたソリューションを提供し、顧客の全体的な治療体験を向上させることができます。これらの戦略は、結果を最適化するだけでなく、個人のニーズと好みを満たすというコミットメントを示し、顧客満足度と忠誠心を高めます。したがって、カスタマイズされた治療計画と他の美容処置との統合は、市場の成長の機会を生み出すことが期待されます。

チャレンジ

  • 長期的な有効性と持続可能性

治療の結果は、代謝、遺伝、ライフスタイルなどの要素によって左右されます。人によっては劇的で長期的な効果を得られるかもしれませんが、望む結果を得るためにより多くのセッションや追加の治療が必要な人もいます。また、持続的な脂肪沈着に対処する場合、長期的な効果を維持することは問題となります。体脂肪を減らす治療は、下腹部やラブハンドルなどの特定の体の部位では効果が低い場合があります。

長期的な有効性と持続可能性は、北米の脂肪減少市場における大きな課題であり、市場の成長に対する課題となることが予想されます。

最近の動向

  • 2023年10月、MOLLER Medicalは2023年6月1日から6月3日まで、SOFCEP Congress 2023というイベントを開催する予定です。このイベントは、美容医療と、美容医療のジェスチャーと介入の相補性をテーマにしています。これにより、同社はより大きな顧客基盤にリーチできるようになります。
  • 2023 年 8 月、Implantech は米国サンディエゴのマリオット マーキス ホテルで開催される第 2 回マルチ専門美容カンファレンスでイベントを開催する予定です。このカンファレンスは、同社がインプラント分野におけるイノベーションを披露するのに役立つでしょう。
  • ヒロニック(株)は2023年5月27日、ソウル中区の韓国プレスセンターで開催されたマネートゥデイ「2023年消費者満足度賞」で美容・医療機器部門大賞を受賞したと発表しました。これは、組織がとりわけブランドイメージを構築するのに役立つでしょう。
  • 2023年1月、FotonaはIMCAS会議で美容製品ポートフォリオを展示すると発表しました。同社は、クールミスト皮膚冷却とオプションのダイナミックバキュームテクノロジーを内蔵したSP Dynamis Nxラインレーザーシステムなどの美容ポートフォリオや、AvalancheLase、TimeWalker Fotona4Dなどの他のFotona製品とアプリケーションが展示され、同社がより多くの顧客ベースに到達するのに役立つと述べました。
  • 2019 年 6 月、Cutera は筋肉彫刻市場向けに truSculpt Flex という新製品を発売しました。同社が発売したこの新製品により、医療美容分野での製品ポートフォリオが拡大し、市場での同社製品の需要が高まります。

北米の脂肪減少市場の範囲

北米の脂肪減少市場は、タイプ、用途、性別、年齢層、エンドユーザー、流通チャネルなど、6 つの主要なセグメントに分割されています。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コア アプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

タイプ

  • 外科的脂肪除去
  • 非侵襲的脂肪減少
  • 低侵襲

タイプに基づいて、北米の脂肪減少市場は、外科的脂肪減少、非侵襲的脂肪減少、および低侵襲性脂肪減少に分類されます。

応用

  • 腹部の脂肪
  • 太ももの脂肪
  • 臀部の脂肪
  • 二の腕の脂肪
  • 顔の脂肪沈着
  • 膝の脂肪

用途に基づいて、北米の脂肪減少市場は、腹部脂肪、太もも脂肪、臀部脂肪、上腕脂肪、顔面脂肪沈着、および膝脂肪に分類されます。

性別

  • 女性

性別に基づいて、北米の脂肪減少市場は男性と女性に分割されます。

年齢層

  • アダルト
  • 老年病
  • 子供

年齢層に基づいて、北米の脂肪減少市場は、成人、高齢者、子供に分類されます。

エンドユーザー

  • 病院
  • 多科クリニック
  • 皮膚科センター
  • メディカルスパとビューティーセンター
  • その他

エンドユーザーに基づいて、北米の脂肪減少市場は、病院、多専門クリニック、皮膚科センター、メディカルスパ、美容センターに分類されます。

流通チャネル

  • 直接入札
  • 小売販売
  • サードパーティ販売業者
  • その他

流通チャネルに基づいて、北米の脂肪減少市場は、直接入札と小売販売、サードパーティの販売業者、その他に分類されます。

北米の脂肪減少市場

北米の脂肪減少市場の地域分析/洞察

北米の脂肪減少市場は、タイプ、用途、性別、年齢層、エンドユーザー、流通チャネルなど、6 つの主要なセグメントに分類されます。

この市場レポートでカバーされている国は、米国、カナダ、メキシコ、コスタリカ、ドミニカ共和国、パナマ、エルサルバドル、グアテマラ、ホンジュラス、ニカラグアです。

米国は、高いGDPを誇る最大の消費者市場に主要な市場プレーヤーが存在することから、北米の脂肪減少市場を支配すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、北米ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。

競争環境と北米の脂肪減少市場シェア分析

北米の脂肪減少市場の競争状況では、競合他社ごとに詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品の承認、製品の幅と幅、アプリケーションの優位性、および製品タイプのライフライン曲線が含まれます。上記のデータ ポイントは、北米の脂肪減少市場への会社の重点にのみ関連しています。

北米の脂肪減少市場で活動している主要企業には、Hironic Co Ltd、AbbVie Inc.、Cynosure、Alma Lasers、Candela Corporation、Merz Pharma、Solta Medical(Bausch & Lomb Incorporatedの子会社)、Cutera、MicroAire Surgical Instruments、LLC、Mentor Worldwide LLC、Venus Concept、、Erchonia Corporation、BTL Group of Companies、Leaderma Inc.、MÖLLER Medical、Fotona、Implantechなどがあります。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA FAT REDUCTION MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET APPLICATION COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 BRAND ANALYSIS

4.3.1 KYBELLA

5 INDUSTRY INSIGHTS:

6 NORTH AMERICA FAT REDUCTION MARKET, REGULATIONS

6.1 U.S.

6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE:

6.1.2 POST-MARKETING SURVEILLANCE:

6.1.3 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES:

6.2 CANADA

6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE

6.2.2 LICENSING AND REGISTRATION

6.2.3 POST EXPIRY OF PATENT REGIME

6.2.4 POST-MARKETING SURVEILLANCE

6.3 MEXICO

6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE

6.3.2 REGULATORY APPROVAL AGENCIES

6.3.3 LICENSING AND REGISTRATION

6.3.4 POST-MARKETING SURVEILLANCE

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES

7.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS

7.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS

7.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES

7.2 RESTRAINTS

7.2.1 HIGH COST OF PROCEDURES

7.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES

7.2.3 PRODUCT RECALL

7.3 OPPORTUNITIES

7.3.1 CUSTOMIZED TREATMENT PLANS AND INTEGRATION WITH OTHER AESTHETIC PROCEDURES

7.3.2 BELIEF AND TREND OF FAT REDUCTION IN YOUNG ADULTS

7.3.3 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES

7.4 CHALLENGES

7.4.1 LONG-TERM EFFICACY AND SUSTAINABILITY

7.4.2 LONGER RECOVERY TIME OF THE PROCEDURE

8 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE

8.1 OVERVIEW

8.2 SURGICAL FAT REDUCTION

8.2.1 LIPOSUCTION

8.2.1.1 BY TYPE

8.2.1.1.1 ULTRASOUND-ASSISTED LIPOSUCTION

8.2.1.1.2 LASER-ASSISTED LIPOSUCTION

8.2.1.1.3 TUMESCENT LIPOSUCTION

8.2.1.1.4 SUPER-WET TECHNIQUE

8.2.1.2 BY APPLICATION

8.2.1.2.1 ABDOMINAL FAT

8.2.1.2.2 THIGHS FAT

8.2.1.2.3 BUTTOCK FAT

8.2.1.2.4 UPPER-ARM FAT

8.2.1.2.5 FACIAL FAT-DEPOSITS

8.2.1.2.5.1 SUBMENTAL AREAS

8.2.1.2.5.2 MALAR

8.2.1.2.5.3 MANDIBULAR

8.2.1.2.6 KNEE FAT

8.2.2 SURGICAL REJUVENATION

8.2.2.1 FACE LIFT

8.2.2.2 NECK LIFT

8.2.3 CHIN IMPLANT

8.2.3.1 SILICONE CHIN IMPLANTS

8.2.3.2 OTHERS

8.2.4 PORUS IMPLANTS

8.2.4.1 TEFLON

8.2.4.2 GORE-TEX

8.2.4.3 MEDPORE IMPLANTS

8.3 NON-INVASIVE FAT REDUCTION

8.3.1 CRYOLIPOLYSIS

8.3.1.1 COOL SCULPTING

8.3.1.2 COOL SCULPTING ELITE

8.3.1.3 COOL TONE

8.3.1.4 OTHERS

8.3.1.4.1 ABDOMINAL FAT

8.3.1.4.2 THIGHS FAT

8.3.1.4.3 BUTTOCK FAT

8.3.1.4.4 UPPER-ARM FAT

8.3.1.4.5 FACIAL FAT-DEPOSITS

8.3.1.4.6 KNEE FAT

8.3.2 ULTRASOUND

8.3.2.1 INTERNAL ULTRASONIC LIPOSUCTION

8.3.2.2 EXTERNAL ULTRASONIC LIPOSUCTION

8.3.2.2.1 ABDOMINAL FAT

8.3.2.2.2 THIGHS FAT

8.3.2.2.3 BUTTOCK FAT

8.3.2.2.4 UPPER-ARM FAT

8.3.2.2.5 FACIAL FAT-DEPOSITS

8.3.2.2.6 KNEE FAT

8.3.3 RADIOFREQUENCY

8.3.3.1 ABDOMINAL FAT

8.3.3.2 THIGHS FAT

8.3.3.3 BUTTOCK FAT

8.3.3.4 UPPER-ARM FAT

8.3.3.5 FACIAL FAT-DEPOSITS

8.3.3.6 KNEE FAT

8.3.4 LOW LEVEL LASER THERAPY

8.3.4.1 ABDOMINAL FAT

8.3.4.2 THIGHS FAT

8.3.4.3 BUTTOCK FAT

8.3.4.4 UPPER-ARM FAT

8.3.4.5 FACIAL FAT-DEPOSITS

8.3.4.6 KNEE FAT

8.3.5 OTHERS

8.4 MINIMALLY INVASIVE

8.4.1 INJECTION LIPOLYSIS

8.4.1.1 DEOXYCHOLIC ACID INJECTIONS

8.4.1.1.1 KYBELLA/BELKYRA

8.4.1.1.1.1 FACIAL FAT-DEPOSITS

8.4.1.1.1.2 UPPER-ARM FAT

8.4.1.1.1.3 ABDOMINAL FAT

8.4.1.1.1.4 THIGHS FAT

8.4.1.1.1.5 KNEE FAT

8.4.1.1.1.6 BUTTOCK FAT

8.4.1.2 PHOSPHATIDYLCHOLINE

8.4.1.2.1 FACIAL FAT-DEPOSITS

8.4.1.2.2 UPPER-ARM FAT

8.4.1.2.3 ABDOMINAL FAT

8.4.1.2.4 THIGHS FAT

8.4.1.2.5 KNEE FAT

8.4.1.2.6 BUTTOCK FAT

8.4.2 OTHERS

9 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 ABDOMINAL FAT

9.3 THIGHS FAT

9.4 BUTTOCK FAT

9.5 UPPER-ARM FAT

9.6 FACIAL FAT-DEPOSITS

9.6.1 SUBMENTAL AREAS

9.6.2 MANDIBULAR

9.6.3 MALAR

9.7 KNEE FAT

10 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER

10.1 OVERVIEW

10.2 FEMALE

10.3 MALE

11 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP

11.1 OVERVIEW

11.2 ADULT

11.3 GERIATRIC

11.4 CHILD

12 NORTH AMERICA FAT REDUCTION MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.2.1 BY TYPE

12.2.1.1 PRIVATE

12.2.1.2 PUBLIC

12.2.2 BY CATEGORY

12.2.2.1 TIER 1

12.2.2.2 TIER 2

12.2.2.3 TIER 3

12.3 MULTISPECIALTY CLINICS

12.4 DERMATOLOGY CENTERS

12.5 MEDICAL SPAS AND BEAUTY CENTERS

12.6 OTHERS

13 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDERS

13.3 RETAIL SALES

13.4 THIRD PARTY DISTRIBUTORS

13.5 OTHERS

14 NORTH AMERICA FAT REDUCTION MARKET, BY COUNTRY

14.1 NORTH AMERICA

14.1.1 U.S.

14.1.2 CANADA

14.1.3 MEXICO

14.1.4 COSTA RICA

14.1.5 DOMINICAN REPUBLIC

14.1.6 PANAMA

14.1.7 EL SALVADOR

14.1.8 GUATEMALA

14.1.9 HONDURAS

14.1.10 NICARAGUA

15 COMPANY SHARE ANALYSIS: NORTH AMERICA

16 SWOT ANALYSIS

17 NORTH AMERICA FAT REDUCTION MARKET, COMPANY PROFILINGS

17.1 ABBVIE INC.

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 PRODUCT PORTFOLIO

17.1.4 RECENT DEVELOPMENTS

17.2 CYNOSURE

17.2.1 COMPANY SNAPSHOT

17.2.2 PRODUCT PORTFOLIO

17.2.3 RECENT DEVELOPMENTS

17.3 ALMA LASERS

17.3.1 COMPANY SNAPSHOT

17.3.2 PRODUCT PORTFOLIO

17.3.3 RECENT DEVELOPMENT

17.4 CANDELA CORPORATION

17.4.1 COMPANY SNAPSHOT

17.4.2 PRODUCT PORTFOLIO

17.4.3 RECENT DEVELOPMENT

17.5 MERZ NORTH AMERICA, INC.

17.5.1 COMPANY SNAPSHOT

17.5.2 PRODUCT PORTFOLIO

17.5.3 RECENT DEVELOPMENTS

17.6 BLACK & BLACK SURGICAL

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENT

17.7 BTL GROUP OF COMPANIES

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENTS

17.8 BAUSCH HEALTH COMPANIES INC.

17.8.1 COMPANY SNAPSHOT

17.8.2 REVENUE ANALYSIS

17.8.3 PRODUCT PORTFOLIO

17.8.4 RECENT DEVELOPMENT

17.9 CUTERA

17.9.1 COMPANY SNAPSHOT

17.9.2 REVENUE ANALYSIS

17.9.3 PRODUCT PORTFOLIO

17.9.4 RECENT DEVELOPMENT

17.1 ERCHONIA CORPORATION

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENT

17.11 FOTONA

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 GENESIS BIOSYSTEMS, INC.

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENT

17.13 HIRONIC CO., LTD.

17.13.1 COMPANY SNAPSHOT

17.13.2 REVENUE ANALYSIS

17.13.3 PRODUCT PORTFOLIO

17.13.4 RECENT DEVELOPMENT

17.14 IMPLANTECH

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENTS

17.15 LEADERMA INC.

17.15.1 COMPANY SNAPSHOT

17.15.2 PRODUCT PORTFOLIO

17.15.3 RECENT DEVELOPMENT

17.16 LYNTON LASERS LTD

17.16.1 COMPANY SNAPSHOT

17.16.2 PRODUCT PORTFOLIO

17.16.3 RECENT DEVELOPMENT

17.17 MENTOR WORLDWIDE LLC (A PART OF JOHNSON & JOHNSON SERVICES, INC.)

17.17.1 COMPANY SNAPSHOT

17.17.2 REVENUE ANALYSIS

17.17.3 PRODUCT PORTFOLIO

17.17.4 RECENT DEVELOPMENT

17.18 MICROAIRE SURGICAL INSTRUMENTS, LLC.

17.18.1 COMPANY SNAPSHOT

17.18.2 PRODUCT PORTFOLIO

17.18.3 RECENT DEVELOPMENT

17.19 MOLLER MEDICAL

17.19.1 COMPANY SNAPSHOT

17.19.2 PRODUCT PORTFOLIO

17.19.3 RECENT DEVELOPMENT

17.2 POLLOGEN (A SUBSIDIARY OF LUMENIS BE LTD.)

17.20.1 COMPANY SNAPSHOT

17.20.2 PRODUCT PORTFOLIO

17.20.3 RECENT DEVELOPMENT

17.21 SILIMED

17.21.1 COMPANY SNAPSHOT

17.21.2 PRODUCT PORTFOLIO

17.21.3 RECENT DEVELOPMENTS

17.22 SURGIFORM INNOVATIVE SURGICAL PRODUCTS

17.22.1 COMPANY SNAPSHOT

17.22.2 PRODUCT PORTFOLIO

17.22.3 RECENT DEVELOPMENT

17.23 VENUS CONCEPT

17.23.1 COMPANY SNAPSHOT

17.23.2 REVENUE ANALYSIS

17.23.3 PRODUCT PORTFOLIO

17.23.4 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

表のリスト

TABLE 1 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S.

TABLE 2 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S.

TABLE 3 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 4 NORTH AMERICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 5 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 6 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 7 NORTH AMERICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 8 NORTH AMERICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 9 NORTH AMERICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 10 NORTH AMERICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 11 NORTH AMERICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 12 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 13 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 14 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION)

TABLE 15 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 16 NORTH AMERICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 17 NORTH AMERICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 18 NORTH AMERICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 19 NORTH AMERICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 20 NORTH AMERICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 21 NORTH AMERICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 22 NORTH AMERICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 23 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 24 NORTH AMERICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 25 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 26 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 27 NORTH AMERICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 28 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 29 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 30 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 31 U.S. FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 32 U.S. SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 33 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 34 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 35 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 36 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 37 U.S. FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 38 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 39 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 40 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 41 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 42 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 43 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 44 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 45 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 46 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 47 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 48 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 49 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 50 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 51 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 52 U.S. CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 53 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 54 U.S.ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 55 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 56 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 57 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 58 U.S. RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 59 U.S. LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 60 U.S. MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 61 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 62 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 63 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 64 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 65 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 66 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 67 U.S. KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 68 U.S. PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 69 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 70 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 71 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 72 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 73 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 74 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 75 U.S. FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 76 U.S. FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 77 U.S. FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 78 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 79 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 80 U.S. FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 81 CANADA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 82 CANADA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 83 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 84 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 85 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 86 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 87 CANADA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 88 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 89 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 90 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 91 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 92 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 93 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 94 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 95 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 96 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 97 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 98 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 99 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 100 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 101 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 102 CANADA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 103 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 104 CANADAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 105 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 106 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 107 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 108 CANADA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 109 CANADA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 110 CANADA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 111 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 112 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 113 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 114 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 115 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 116 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 117 CANADA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 118 CANADA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 119 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 120 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 121 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 122 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 123 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 124 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 125 CANADA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 126 CANADA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 127 CANADA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 128 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 129 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 130 CANADA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 131 MEXICO FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 132 MEXICO SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 133 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 134 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 135 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 136 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 137 MEXICO FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 138 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 139 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 140 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 141 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 142 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 143 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 144 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 145 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 146 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 147 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 148 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 149 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 150 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 151 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 152 MEXICO CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 153 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 154 MEXICOULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 155 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 156 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 157 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 158 MEXICO RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 159 MEXICO LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 160 MEXICO MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 161 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 162 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 163 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 164 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 165 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 166 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 167 MEXICO KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 168 MEXICO PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 169 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 170 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 171 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 172 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 173 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 174 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 175 MEXICO FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 176 MEXICO FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 177 MEXICO FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 178 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 179 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 180 MEXICO FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 181 COSTA RICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 182 COSTA RICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 183 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 184 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 185 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 186 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 187 COSTA RICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 188 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 189 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 190 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 191 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 192 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 193 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 194 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 195 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 196 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 197 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 198 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 199 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 200 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 201 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 202 COSTA RICA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 203 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 204 COSTA RICAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 205 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 206 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 207 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 208 COSTA RICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 209 COSTA RICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 210 COSTA RICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 211 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 212 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 213 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 214 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 215 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 216 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 217 COSTA RICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 218 COSTA RICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 219 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 220 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 221 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 222 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 223 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 224 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 225 COSTA RICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 226 COSTA RICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 227 COSTA RICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 228 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 229 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 230 COSTA RICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 231 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 232 DOMINICAN REPUBLIC SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 233 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 234 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 235 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 236 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 237 DOMINICAN REPUBLIC FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 238 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 239 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 240 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 241 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 242 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 243 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 244 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 245 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 246 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 247 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 248 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 249 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 250 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 251 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 252 DOMINICAN REPUBLIC CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 253 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 254 DOMINICAN REPUBLICULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 255 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 256 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 257 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 258 DOMINICAN REPUBLIC RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 259 DOMINICAN REPUBLIC LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 260 DOMINICAN REPUBLIC MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 261 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 262 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 263 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 264 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 265 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 266 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 267 DOMINICAN REPUBLIC KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 268 DOMINICAN REPUBLIC PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 269 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 270 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 271 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 272 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 273 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 274 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 275 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 276 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 277 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 278 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 279 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 280 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 281 PANAMA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 282 PANAMA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 283 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 284 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 285 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 286 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 287 PANAMA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 288 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 289 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 290 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 291 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 292 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 293 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 294 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 295 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 296 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 297 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 298 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 299 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 300 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 301 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 302 PANAMA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 303 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 304 PANAMAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 305 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 306 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 307 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 308 PANAMA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 309 PANAMA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 310 PANAMA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 311 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 312 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 313 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 314 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 315 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 316 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 317 PANAMA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 318 PANAMA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 319 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 320 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 321 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 322 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 323 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 324 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 325 PANAMA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 326 PANAMA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 327 PANAMA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 328 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 329 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 330 PANAMA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 331 EL SALVADOR FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 332 EL SALVADOR SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 333 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 334 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 335 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 336 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 337 EL SALVADOR FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 338 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 339 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 340 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 341 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 342 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 343 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 344 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 345 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 346 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 347 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 348 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 349 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 350 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 351 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 352 EL SALVADOR CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 353 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 354 EL SALVADORULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 355 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 356 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 357 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 358 EL SALVADOR RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 359 EL SALVADOR LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 360 EL SALVADOR MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 361 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 362 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 363 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 364 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 365 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 366 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 367 EL SALVADOR KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 368 EL SALVADOR PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 369 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 370 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 371 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 372 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 373 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 374 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 375 EL SALVADOR FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 376 EL SALVADOR FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 377 EL SALVADOR FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 378 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 379 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 380 EL SALVADOR FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 381 GUATEMALA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 382 GUATEMALA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 383 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 384 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 385 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 386 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 387 GUATEMALA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 388 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 389 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 390 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 391 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 392 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 393 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 394 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 395 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 396 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 397 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 398 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 399 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 400 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 401 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 402 GUATEMALA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 403 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 404 GUATEMALAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 405 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 406 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 407 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 408 GUATEMALA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 409 GUATEMALA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 410 GUATEMALA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 411 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 412 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 413 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 414 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 415 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 416 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 417 GUATEMALA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 418 GUATEMALA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 419 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 420 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 421 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 422 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 423 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 424 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 425 GUATEMALA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 426 GUATEMALA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 427 GUATEMALA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 428 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 429 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 430 GUATEMALA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 431 HONDURAS FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 432 HONDURAS SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 433 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 434 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 435 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 436 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 437 HONDURAS FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 438 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 439 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 440 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 441 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 442 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 443 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 444 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 445 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 446 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 447 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 448 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 449 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 450 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 451 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 452 HONDURAS CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 453 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 454 HONDURASULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 455 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 456 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 457 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 458 HONDURAS RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 459 HONDURAS LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 460 HONDURAS MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 461 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 462 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 463 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 464 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 465 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 466 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 467 HONDURAS KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 468 HONDURAS PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 469 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 470 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 471 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 472 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 473 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 474 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 475 HONDURAS FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 476 HONDURAS FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 477 HONDURAS FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 478 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 479 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 480 HONDURAS FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

TABLE 481 NICARAGUA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 482 NICARAGUA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 483 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 484 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 485 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 486 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 487 NICARAGUA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 488 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 489 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 490 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 491 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)

TABLE 492 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 493 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP

TABLE 494 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 495 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 496 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 497 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 498 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 499 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 500 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 501 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 502 NICARAGUA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 503 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 504 NICARAGUAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 505 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 506 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 507 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 508 NICARAGUA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 509 NICARAGUA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 510 NICARAGUA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 511 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 512 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 513 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP

TABLE 514 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)

TABLE 515 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 516 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP

TABLE 517 NICARAGUA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 518 NICARAGUA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 519 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 520 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 521 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 522 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)

TABLE 523 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)

TABLE 524 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP

TABLE 525 NICARAGUA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)

TABLE 526 NICARAGUA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)

TABLE 527 NICARAGUA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)

TABLE 528 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)

TABLE 529 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)

TABLE 530 NICARAGUA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)

図表一覧

FIGURE 1 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA FAT REDUCTION MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA FAT REDUCTION MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA FAT REDUCTION MARKET: COUNTRY VS. REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA FAT REDUCTION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA FAT REDUCTION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA FAT REDUCTION MARKET: MULTIVARIATE MODELLING

FIGURE 8 NORTH AMERICA FAT REDUCTION MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA FAT REDUCTION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA FAT REDUCTION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION

FIGURE 12 INCREASING DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES IS EXPECTED TO DRIVE THE NORTH AMERICA FAT REDUCTION MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2033

FIGURE 13 THE SURGICAL FAT REDUCTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FAT REDUCTION MARKET IN 2023 & 2033

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FAT REDUCTION MARKET

FIGURE 15 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2022

FIGURE 16 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2023-2033 (USD MILLION)

FIGURE 17 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, CAGR (2023-2033)

FIGURE 18 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, LIFELINE CURVE

FIGURE 19 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2022

FIGURE 20 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2023-2033 (USD MILLION)

FIGURE 21 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, CAGR (2023-2033)

FIGURE 22 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 23 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2022

FIGURE 24 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2023-2033 (USD MILLION)

FIGURE 25 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, CAGR (2023-2033)

FIGURE 26 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, LIFELINE CURVE

FIGURE 27 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2022

FIGURE 28 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2023-2033 (USD MILLION)

FIGURE 29 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, CAGR (2023-2033)

FIGURE 30 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 31 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2022

FIGURE 32 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2023-2033 (USD MILLION)

FIGURE 33 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, CAGR (2023-2033)

FIGURE 34 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, LIFELINE CURVE

FIGURE 35 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 36 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2033 (USD MILLION)

FIGURE 37 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2033)

FIGURE 38 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 39 NORTH AMERICA FAT REDUCTION MARKET: SNAPSHOT (2022)

FIGURE 40 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022)

FIGURE 41 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2023 & 2033)

FIGURE 42 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022 & 2033)

FIGURE 43 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE (2023-2033)

FIGURE 44 NORTH AMERICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Testimonial